← Back to Search

Other

Small Phlebotomy Tubes for Anemia in ICU Patients

N/A
Recruiting
Led By Javier Barreda Garcia, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial evaluates the effectiveness of smaller tubes to reduce RBC transfusions in ICU/IMU patients with low hemoglobin & assess their acceptability.

Who is the study for?
This trial is for adults in the ICU or IMU with anemia, specifically those with hemoglobin levels below 9 g/dL. It's not suitable for patients with active bleeding, blood or bone marrow disorders, Jehovah's Witnesses, those on comfort care only, refractory shock patients, severe acidosis cases without diabetic ketoacidosis, surgical admission diagnoses, pregnant women or prisoners.
What is being tested?
The study compares small phlebotomy tubes against standard ones to see if they reduce the need for red blood cell transfusions in anemic ICU/IMU patients. It also looks at how these groups differ in terms of ICU/hospital stay length and mortality rates while assessing the acceptability of using small tubes.
What are the potential side effects?
Since this trial involves different sizes of phlebotomy tubes rather than medications or invasive procedures, side effects are minimal and primarily related to discomfort from blood draws.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Small Tube GroupExperimental Treatment1 Intervention
Group II: Standard Tube GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
950 Previous Clinical Trials
344,357 Total Patients Enrolled
3 Trials studying Anemia
1,718 Patients Enrolled for Anemia
Javier Barreda Garcia, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
200 Total Patients Enrolled
1 Trials studying Anemia
200 Patients Enrolled for Anemia

Media Library

Small Phlebotomy Tube Group (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05750654 — N/A
Anemia Research Study Groups: Small Tube Group, Standard Tube Group
Anemia Clinical Trial 2023: Small Phlebotomy Tube Group Highlights & Side Effects. Trial Name: NCT05750654 — N/A
Small Phlebotomy Tube Group (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05750654 — N/A
~229 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top